阑尾切除术后选择性病理检查的肿瘤学安全性与成本节约:FANCY 多中心前瞻性横断面研究
该多中心前瞻性横断面研究纳入 7339 例疑似阑尾炎患者,评估阑尾切除术后选择性病理检查的肿瘤学安全性及成本节约。选择性策略下 67.7% 标本可免于病理检查,有临床获益的肿瘤漏诊率为 1.01:1000(95%CI 上限 1.61:1000),低于预设安全性阈值 3:1000,每万例患者估计节约 €725,400。
要点
- 选择性病理策略下 67.7% 标本可免检,有临床获益的肿瘤漏诊率 1.01:1000,95%CI 上限 1.61:1000,低于预设安全阈值 3:1000。
- 22 例漏诊肿瘤中 5 例残余病灶经额外手术完全切除,10 例免于无明确获益的再切除潜在伤害。
- 以选择性替代常规病理检查,估计每万例患者节约 €725,400。
核心结论
- 疑似阑尾炎阑尾切除术后选择性病理检查在肿瘤学上是安全的,可能减少病理工作量、降低成本并减少无明确获益的再切除。
研究设计与样本
- 多中心、前瞻性、横断面研究,纳入 7339 例疑似阑尾炎患者;由外科医生对(阑尾系膜)阑尾进行视诊和触诊,并在送检前报告对病理检查附加价值的意见。
主要发现
- 选择性策略下 4966/7339(67.7%)标本可免于病理检查。
- 有临床后果的阑尾肿瘤在 22/4966 例患者中被漏诊;其中 5/22 例残余病灶经额外手术完全切除。
- 有临床获益的阑尾肿瘤漏诊率为 1.01:1000 患者(95%CI 上限 1.61:1000)。
- 10/22 例患者免于无明确获益再切除的潜在伤害,其余 7 例后果既无获益也无伤害。
- 以选择性替代常规病理检查,估计每 10,000 例患者节约 €725,400。
关键数值与推荐
- 预设肿瘤学安全标准:有临床获益的漏诊肿瘤上限双侧 95%CI 低于 3:1000。
- 实际结果:有临床获益的阑尾肿瘤漏诊率 1.01:1000,95%CI 上限 1.61:1000,满足预设安全标准。
临床怎么用
- 疑似阑尾炎阑尾切除术后,外科医生可基于术中(阑尾系膜)阑尾视诊和触诊及对病理附加价值的判断,选择性决定是否送病理检查。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the oncological safety and potential cost savings of selective histopathological examination after appendectomy. BACKGROUND: The necessity of routine histopathological examination after appendectomy has been questioned, but prospective studies investigating the safety of a selective policy are lacking. METHODS: In this multicenter, prospective, cross-sectional study, inspection and palpation of the (meso)appendix was performed by the surgeon in patients with suspected appendicitis. The surgeon's opinion on additional value of histopathological examination was reported before sending all specimens to the pathologist. Main outcomes were the number of hypothetically missed appendiceal neoplasms with clinical consequences benefiting the patient (upper limit two-sided 95% confidence interval below 3:1000 considered oncologically safe) and potential cost savings after selective histopathological examination. RESULTS: Seven thousand three hundred thirty-nine patients were included. After a selective policy, 4966/7339 (67.7%) specimens would have been refrained from histopathological examination. Appendiceal neoplasms with clinical consequences would have been missed in 22/4966 patients. In 5/22, residual disease was completely resected during additional surgery. Hence, an appendiceal neoplasm with clinical consequences benefiting the patient would have been missed in 1.01:1000 patients (upper limit 95% confidence interval 1.61:1000). In contrast, twice as many patients (10/22) would not have been exposed to potential harm due to re-resections without clear benefit, whereas consequences were neither beneficial nor harmful in the remaining seven. Estimated cost savings established by replacing routine for selective histopathological examination were €725,400 per 10,000 patients. CONCLUSIONS: Selective histopathological examination after appendectomy for suspected appendicitis is oncologically safe and will likely result in a reduction of pathologists' workload, less costs, and fewer re-resections without clear benefit.
引用
- Bastiaenen VP, de Jonge J, Corten BJGA, et al. Oncological Safety and Potential Cost Savings of Routine vs Selective Histopathological Examination After Appendectomy: Results of the Multicenter, Prospective, Cross-Sectional FANCY Study. Ann Surg. 2021. PMID: 35072428. doi:10.1097/SLA.0000000000005228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。